Monitor for future prospectus supplements that would indicate an actual offering, which could lead to near-term dilution or increased leverage. The shelf provides financial flexibility but creates uncertainty around future capital structure.
Price Chart
Executive Summary
Assembly Biosciences' $400 million shelf registration (S-3) has become effective, allowing the company to issue common stock, preferred stock, debt securities, warrants, subscription rights, or units from time to time. This creates a potential dilution overhang but provides capital flexibility for future needs.
Key Facts
- S-3 shelf registration effective as of March 27, 2026
- Maximum aggregate offering price of $400,000,000
- Securities may include common stock, preferred stock, debt, warrants, subscription rights, or units
- Offerings can be taken down at any time over the next three years
- This is a follow-on shelf registration, not an IPO
Financial Impact
Up to $400 million in potential future dilution or debt issuance
Risk Factors
- Potential share dilution if equity is issued
- Increased debt burden if debt securities are issued
- Market perception of dilution overhang could pressure stock price
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-000970 |
| Document: 9999999995-26-000970-index.html | 9999999995-26-000970 |
| Document: 9999999995-26-000970.txt | 9999999995-26-000970 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 15, 2026 10w ago | Institutional Cluster | $30.01 $35.28 | ▲ +17.56% | ▲ +18.75% | $20.30 (−32.36%) |
Aug 13, 2026 10w ago | Press Release | $32.95 $34.38 | ▲ +4.34% | ▲ +5.71% | $20.30 (−38.39%) |
Jun 11, 2026 19w ago | Institutional Cluster | $22.53 $24.15 | ▲ +7.19% | ▲ +6.76% | $20.30 (−9.90%) |
Jun 5, 2026 20w ago | 8-K | $22.56 $23.34 | ▲ +3.48% | ▲ +1.37% | $20.30 (−10.00%) |
May 22, 2026 22w ago | 424B5 | $28.75 $26.92 | ▲ +6.37% | ▲ +7.45% | $20.30 (+29.39%) |
May 22, 2026 22w ago | 8-K | $28.34 $26.92 | ▼ −5.01% | ▼ −6.67% | $20.30 (−28.37%) |
May 22, 2026 22w ago | Press Release | $28.34 $26.92 | ▼ −5.01% | ▼ −6.67% | $20.30 (−28.37%) |
May 7, 2026 24w ago | Press Release | $29.74 $30.30 | ▲ +1.88% | ▲ +0.42% | $20.30 (−31.74%) |
Mar 30, 2026 30w ago | EFFECT | $26.64 $28.53 | ▲ +7.09% | ▲ +2.79% | $20.30 (−23.80%) |
Mar 19, 2026 31w ago | Press Release | $28.46 $27.70 | ▼ −2.67% | ▼ −0.52% | $20.30 (−28.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers